Table 3.
Characteristics of subjects with HBsAg seroclearance and reappearance
| Subject | Sex | Age | Genotype | Baseline viral load | HBeAg | ALT | July 2004 | Feb. 2005 | Aug. 2005 | Mar. 2006 | Sept. 2006 | June 2007 | Dec. 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BB255 | F | 53 | C | 737·7 | − | − | + | − | − | − | n.d. | n.d. | − |
| GA102 | F | 36 | U | 1933 | − | − | + | n.d. | n.d. | − | − | − | − |
| NF120 | F | 50 | B | 3509 | − | − | + | + | + | − | − | − | − |
| QS840 | M | 39 | C | 41·92 | + | − | + | − | − | − | − | − | + |
| QZ550 | M | 42 | C | 11 482 | − | − | + | n.d. | − | − | − | − | − |
| TF336 | F | 34 | C | 9·5 × 105 | n.d. | n.d. | + | − | − | n.d. | − | n.d. | + |
| TF405 | M | 30 | C | 701·5 | − | + | + | − | n.d. | − | − | − | − |
| TL203 | M | 35 | n.d. | 168·9 | − | − | + | − | − | n.d. | − | − | − |
| TM015 | F | 41 | C | 769·1 | − | − | + | + | − | n.d. | − | − | − |
| TN98 | F | 40 | C | 135·1 | − | − | + | − | − | − | − | − | + |
| TS117 | F | 50 | C | 57. 9 | − | − | + | + | − | − | − | − | − |
| TW126 | F | 39 | n.d. | 4·8 | − | − | + | − | − | − | n.d. | − | − |
| WX227 | M | 40 | C | 4816 | − | + | + | + | + | − | − | − | + |
ALT, Alanine aminotransferase; n.d., not done.